The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
about
CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markersNeoplasia: Where We Have Been and Where We Are GoingNeoplasia: the second decade.Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone.c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.Immunohistochemical characterization of 13 canine renal cell carcinomas.Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11.Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor.RETRACTED: Uterine mast cell tumor: a clinical and cytohistopathological study.Beyond H&E: integration of nucleic acid-based analyses into diagnostic pathology.Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell TumorsGalectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.C-kit and its ligand stem cell factor: potential contribution to prostate cancer bone metastasisAdvances in the diagnosis and management of cutaneous mast cell tumours in dogs.Breed-predispositions to cancer in pedigree dogs.Concordance of c-kit mutational status in matched primary and metastatic cutaneous canine mast cell tumors at baselineStem cell growth factor receptor in canine vs. feline osteosarcomas.The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumorsMulticenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.The Relevance of CD117-Immunocytochemistry Staining Patterns to Mutational Exon-11 in c-kit Detected by PCR from Fine-Needle Aspirated Canine Mast Cell Tumor Cells.Expression of Phosphorylated KIT in Canine Mast Cell Tumor.Comparison of histologic margin status in low-grade cutaneous and subcutaneous canine mast cell tumours examined by radial and tangential sections.Surgical margins in the veterinary cancer patient.KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.Clinical response of masitinib mesylate in the treatment of canine macroscopic mast cell tumours.Cutaneous epitheliotropic lymphoma with dual CD3 and c-kit expression in a dog.Veterinary and human biobanking practices: enhancing molecular sample integrity.Genomic profiling of canine mast cell tumors identifies DNA copy number aberrations associated with KIT mutations and high histological grade.Classification of canine nonangiogenic, nonlymphogenic, gastrointestinal sarcomas based on microscopic, immunohistochemical, and molecular characteristics.The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.Immunohistochemical expression of c-KIT protein in feline soft tissue fibrosarcomas.Neoplasia: An Anniversary of Progress.Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine.Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study.Clinical, histological, immunohistochemical and genetic factors associated with measurable response of high-risk canine mast cell tumours to tyrosine kinase inhibitors.Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures.The use of COLD-PCR, DHPLC and GeneScanning for the highly sensitive detection of c-KIT somatic mutations in canine mast cell tumours.
P2860
Q21203579-A38308F3-7E3A-4C11-8B21-D6850BEC340CQ28395095-9E2D4079-33FB-4C83-8BD5-88FA81A53117Q30484000-CB91E618-4974-432E-BF00-1328E244B12AQ33238296-19C27E6A-D83D-46F5-A0A0-1E7446D1E581Q33359882-711CA258-277B-47D0-8BDD-3F8524403AD5Q33677797-EFF22BBC-9CDB-4F28-A6CF-8F0F0C8654D5Q33699701-8AEB3C27-B25B-4398-AF05-91A2464119CEQ33719838-E729A042-6297-420B-AECD-C4DD5E6C5FDFQ33726782-8904EB36-C8BC-4CA6-A9C3-9FD1985D65D6Q34568506-286CB6C9-9E3B-47CA-81F1-387DDC375C88Q35017911-970E9243-6A7B-45A0-8D24-7D58FC7111C0Q35839839-4B116975-9FE7-44E7-9414-4E124D85AF47Q35945071-5D712FC6-612E-4C6C-B5CC-3230249DFB5CQ36840289-CD3A0AB3-E5A5-4CC6-A9DD-8BC5AA75A8DBQ36845216-91E9C2D3-70A0-43A9-92A6-763BAB56272DQ36857180-A18F9368-80F5-435C-93AE-22425BD0B5C0Q36873386-F5143F63-686A-40EC-8A78-356048E267FBQ37288229-5BE341EE-5332-4C13-8869-1E0AE298EA1FQ37333665-81CE53F2-C9B6-4E3B-A5FB-222426C89E83Q37333673-5A1D3C14-30EB-4809-85E0-1EDDEAFC21D7Q38255489-39D5E68A-2A17-458C-A4A6-04AB8526A545Q38376182-13A62576-8CD2-4E38-B32A-64F1D6226108Q38678959-5989A576-1B30-4817-8D73-2E016C7C4044Q38757865-A73CC943-4956-45B2-9F40-9A88521826EBQ38798420-A96A1E9D-DF21-44B7-AD0B-70697CFA01C4Q38823163-68A1BFD1-65A3-4AAB-82DF-3DCA12CF0174Q39533782-90200F4B-8AD0-443B-AEAA-BD60F4557BFAQ40150160-C86BE281-E608-4599-BD3F-CAC089AB0844Q40433142-FE8ACCA6-9C90-47F5-8633-DE55FC16C066Q43490888-724D342E-F089-41A0-B6DD-0A074D2F9F88Q43727603-4CA882DC-63C2-4FF6-92B3-5D69A3DD03E6Q46017458-E3C41D7C-57C3-4B56-BAB7-4C2876F39F17Q46932476-85A0151A-0A19-4003-9BD3-FF9749EB54CCQ47742852-C99C0B79-9737-4ED3-BCE6-7041D7775556Q48196847-113D1CD3-CA9B-4E9A-BB91-DB362C39F64EQ48199116-FECAC40D-F55F-4326-AA37-07D3A47621ABQ49310990-3894D7FB-C178-45D3-BD83-D61C5BB4CE08Q50025491-FFFC2CA3-3B1C-46C6-B988-2451EF68F7E5Q50241634-2FFA0A72-694E-4E9B-A53D-86655D9A95B5Q51011082-A275160E-899C-4073-AE1E-21968552E31D
P2860
The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
@ast
The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
@en
type
label
The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
@ast
The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
@en
prefLabel
The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
@ast
The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
@en
P2093
P2860
P356
P1433
P1476
The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
@en
P2093
James H Resau
John B Kaneene
Joshua D Webster
Matti Kiupel
RoseAnn Miller
Vilma Yuzbasiyan-Gurkan
P2860
P304
P356
10.1593/NEO.05622
P577
2006-02-01T00:00:00Z